1887

Journal of General Virology header logo

Volume 90, Issue 6

Peptide inhibitors of hepatitis C virus core oligomerization and virus production Free

Abstract

Hepatitis C virus (HCV) nucleocapsid assembly requires dimerization of the core protein, an essential step in the formation of the virus particle. We developed a novel quantitative assay for monitoring this protein–protein interaction, with the goal of identifying inhibitors of core dimerization that might block HCV production in infected Huh-7.5 hepatoma cells. Two core-derived, 18-residue peptides were found that inhibited the dimerization of a fragment of core comprising residues 1–106 (core106) by 68 and 63 %, respectively. A third, related 15-residue peptide displayed 50 % inhibition, with an IC of 21.9 μM. This peptide was shown, by fluorescence polarization, to bind directly to core106 with a of 1.9 μM and was displaced by the unlabelled peptide with an IC of 18.7 μM. When measured by surface plasmon resonance, the same peptide bound core169 with a of 7.2 μM. When added to HCV-infected cells, each of the three peptides blocked release, but not replication, of infectious virus. When measured by real-time RT-PCR, the RNA levels were reduced by 7-fold. The 15-residue peptide had no effect on HIV propagation. Such inhibitors may constitute useful tools to investigate the role of core dimerization in the virus cycle.

  • Received:
  • Accepted:
  • Published Online:
SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.008565-0
2009-06-01
2024-04-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/90/6/1319.html?itemId=/content/journal/jgv/10.1099/vir.0.008565-0&mimeType=html&fmt=ahah

References

  1. Boulant S., Vanbelle C., Ebel C., Penin F., Lavergne J. P. 2005; Hepatitis C virus core protein is a dimeric alpha-helical protein exhibiting membrane protein features. J Virol 79:11353–11365 [CrossRef]
     [Google Scholar]
  2. Chen W., Zhang Z., Chen J., Zhang J., Zhang J., Wu Y., Huang Y., Cai X., Huang A. 2008; HCV core protein interacts with Dicer to antagonize RNA silencing. Virus Res 133:250–258 [CrossRef]
     [Google Scholar]
  3. Cheng G., Montero A., Gastaminza P., Whitten-Bauer C., Wieland S. F., Isogawa M., Fredericksen B., Selvarajah S., Gallay P. A. other authors 2008; A virocidal amphipathic α -helical peptide that inhibits hepatitis C virus infection in vitro . Proc Natl Acad Sci U S A 105:3088–3093 [CrossRef]
     [Google Scholar]
  4. Choo Q. L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M. 1989; Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359 [CrossRef]
     [Google Scholar]
  5. Dandliker W. B., Kelly R. J., Dandliker J., Farquahar J., Levin J. 1973; Fluorescence polarization immunoassay. Theory and experimental method. Immunochemistry 10:219–227 [CrossRef]
     [Google Scholar]
  6. De Francesco R., Carfí A. 2007; Advances in the development of new therapeutic agents targeting the NS3–4A serine protease or the NS5B RNA-dependent RNA polymerase of the hepatitis C virus. Adv Drug Deliv Rev 59:1242–1262 [CrossRef]
     [Google Scholar]
  7. Flajolet M., Rotondo G., Daviet L., Bergametti F., Inchauspé G., Tiollais P., Transy C., Legrain P. 2000; A genomic approach of the hepatitis C virus generates a protein interaction map. Gene 242:369–379 [CrossRef]
     [Google Scholar]
  8. Fromentin R., Majeau N., Laliberté Gagné M. E., Boivin A., Duvignaud J. B., Leclerc D. 2007; A method for in vitro assembly of hepatitis C virus core protein and for screening of inhibitors. Anal Biochem 366:37–45 [CrossRef]
     [Google Scholar]
  9. Giannini C., Brechot C. 2003; Hepatitis C virus biology. Cell Death Differ 10:S27–S38 [CrossRef]
     [Google Scholar]
  10. Grakoui A., Wychowski C., Lin C., Feinstone S. M., Rice C. M. 1993; Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 67:1385–1395
     [Google Scholar]
  11. Hijikata M., Kato N., Ootsuyama Y., Nakagawa M., Shimotohno K. 1991; Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc Natl Acad Sci U S A 88:5547–5551 [CrossRef]
     [Google Scholar]
  12. Jones C. T., Murray C. L., Eastman D. K., Tassello J., Rice C. M. 2007; Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus. J Virol 81:8374–8383 [CrossRef]
     [Google Scholar]
  13. Klein K. C., Polyak S. J., Lingappa J. R. 2004; Unique features of hepatitis C virus capsid formation revealed by de novo cell-free assembly. J Virol 78:9257–9269 [CrossRef]
     [Google Scholar]
  14. Klein K. C., Dellos S. R., Lingappa J. R. 2005; Identification of residues in the hepatitis C virus core protein that are critical for capsid assembly in a cell-free system. J Virol 79:6814–6826 [CrossRef]
     [Google Scholar]
  15. Kunkel M., Lorinczi M., Rijnbrand R., Lemon S. M., Watowich S. J. 2001; Self-assembly of nucleocapsid-like particles from recombinant hepatitis C virus core protein. J Virol 75:2119–2129 [CrossRef]
     [Google Scholar]
  16. Lindenbach B. D., Rice C. M. 2005; Unravelling hepatitis C virus replication from genome to function. Nature 436:933–938 [CrossRef]
     [Google Scholar]
  17. Lindenbach B. D., Evans M. J., Syder A. J., Wolk B., Tellinghuisen T. L., Liu C. C., Maruyama T., Hynes R. O., Burton D. R. other authors 2005; Complete replication of hepatitis C virus in cell culture. Science 309:623–626 [CrossRef]
     [Google Scholar]
  18. Liu Q., Tackney C., Bhat R. A., Prince A. M., Zhang P. 1997; Regulated processing of hepatitis C virus core protein is linked to subcellular localization. J Virol 71:657–662
     [Google Scholar]
  19. Lo S. Y., Selby M. J., Ou J. H. 1996; Interaction between hepatitis C virus core protein and E1 envelope protein. J Virol 70:5177–5182
     [Google Scholar]
  20. Ma H. C., Ke C. H., Hsieh T. Y., Lo S. Y. 2002; The first hydrophobic domain of the hepatitis C virus E1 protein is important for interaction with the capsid protein. J Gen Virol 83:3085–3092
     [Google Scholar]
  21. Maillard P., Lavergne J. P., Siberil S., Faure G., Roohvand F., Petres S., Teillaud J. L., Budkowska A. 2004; Fc γ receptor-like activity of hepatitis C virus core protein. J Biol Chem 279:2430–2437 [CrossRef]
     [Google Scholar]
  22. Majeau N., Gagne V., Boivin A., Bolduc M., Majeau J. A., Ouellet D., Leclerc D. 2004; The N-terminal half of the core protein of hepatitis C virus is sufficient for nucleocapsid formation. J Gen Virol 85:971–981 [CrossRef]
     [Google Scholar]
  23. McLauchlan J. 2000; Properties of the hepatitis C virus core protein: a structural protein that modulates cellular processes. J Viral Hepat 7:2–14 [CrossRef]
     [Google Scholar]
  24. McLauchlan J., Lamberg M. K., Hope G., Martoglio B. 2002; Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets. EMBO J 21:3980–3988 [CrossRef]
     [Google Scholar]
  25. Miyanari Y., Atsuzawa K., Usuda N., Watashi K., Hishiki T., Zayas M., Bartenschlager R., Wakita T., Hijikata M., Shimotohno K. 2007; The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 9:1089–1097 [CrossRef]
     [Google Scholar]
  26. Murray C. L., Jones C. T., Tassello J., Rice C. M. 2007; Alanine scanning of the hepatitis C virus core protein reveals numerous residues essential for infectious virus production. J Virol 81:10220–10231 [CrossRef]
     [Google Scholar]
  27. Nolandt O., Kern V., Muller H., Pfaff E., Theilmann L., Welker R., Krausslich H. G. 1997; Analysis of hepatitis C virus core protein interaction domains. J Gen Virol 78:1331–1340
     [Google Scholar]
  28. Okamoto K., Mori Y., Komoda Y., Okamoto T., Okochi M., Takeda M., Suzuki T., Moriishi K., Matsuura Y. 2008; Intramembrane processing by signal peptide peptidase regulates the membrane localization of hepatitis C virus core protein and viral propagation. J Virol 82:8349–8361 [CrossRef]
     [Google Scholar]
  29. Paeshuyse J., Kaul A., De Clercq E., Rosenwirth B., Dumont J. M., Scalfaro P., Bartenschlager R., Neyts J. 2006; The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro . Hepatology 43:761–770 [CrossRef]
     [Google Scholar]
  30. Penin F., Dubuisson J., Rey F. A., Moradpour D., Pawlotsky J. M. 2004; Structural biology of hepatitis C virus. Hepatology 39:5–19 [CrossRef]
     [Google Scholar]
  31. Peppard J., Glickman F., He Y., Hu S. I., Doughty J., Goldberg R. 2003; Development of a high-throughput screening assay for inhibitors of aggrecan cleavage using luminescent oxygen channeling (AlphaScreen). J Biomol Screen 8:149–156 [CrossRef]
     [Google Scholar]
  32. Roingeard P., Hourioux C. 2008; Hepatitis C virus core protein, lipid droplets and steatosis. J Viral Hepat 15:157–164
     [Google Scholar]
  33. Shavinskaya A., Boulant S., Penin F., McLauchlan J., Bartenschlager R. 2007; The lipid droplet binding domain of hepatitis C virus core protein is a major determinant for efficient virus assembly. J Biol Chem 282:37158–37169 [CrossRef]
     [Google Scholar]
  34. Suzuki R., Sakamoto S., Tsutsumi T., Rikimaru A., Tanaka K., Shimoike T., Moriishi K., Iwasaki T., Mizumoto K. other authors 2005; Molecular determinants for subcellular localization of hepatitis C virus core protein. J Virol 79:1271–1281 [CrossRef]
     [Google Scholar]
  35. Tellinghuisen T. L., Foss K. L., Treadaway J. 2008; Regulation of hepatitis C virion production via phosphorylation of the NS5A protein. PLoS Pathog 4:e1000032 [CrossRef]
     [Google Scholar]
  36. Thibeault D., Bousquet C., Gingras R., Lagace L., Maurice R., White P. W., Lamarre D. 2004; Sensitivity of NS3 serine proteases from hepatitis C virus genotypes 2 and 3 to the inhibitor BILN 2061. J Virol 78:7352–7359 [CrossRef]
     [Google Scholar]
  37. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Krausslich H. G. other authors 2005; Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11:791–796 [CrossRef]
     [Google Scholar]
  38. Wells J. A., McClendon C. L. 2007; Reaching for high-hanging fruit in drug discovery at protein–protein interfaces. Nature 450:1001–1009 [CrossRef]
     [Google Scholar]
  39. Yan X.-B., Battaglia S., Boucreux D., Chen Z., Brechot C., Pavio N. 2007; Mapping of the interacting domains of hepatitis C virus core protein and the double-stranded RNA- activated protein kinase PKR. Virus Res 125:79–87 [CrossRef]
     [Google Scholar]
  40. Zhong J., Gastaminza P., Cheng G., Kapadia S., Kato T., Burton D. R., Wieland S. F., Uprichard S. L., Wakita T., Chisari F. V. 2005; Robust hepatitis C virus infection in vitro . Proc Natl Acad Sci U S A 102:9294–9299 [CrossRef]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.008565-0
Loading
Peptide inhibitors of hepatitis C virus core oligomerization and virus production
J. Gen. Virol. 90, 1319 (2009); https://doi.org/10.1099/vir.0.008565-0
/content/journal/jgv/10.1099/vir.0.008565-0
/content/journal/jgv/10.1099/vir.0.008565-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error